Cristina Alaimo | Head of Clinical, Senior Director Clinical and Regulatory
Limmatech

Cristina Alaimo is a microbiologist with over 20 years of experience in the biotechnology industry and vaccine development. As Head of Clinical and Regulatory, Cristina is responsible for LimmaTech Biologics’ clinical trials, to advance innovative vaccine candidates from preclinical stages into clinical development. Cristina has a degree in Molecular Biology and a master in Clinical Microbiology and Virology. She obtained a PhD at the Microbiology Institute of the ETH in Zürich, working on bioconjugation, the technology that was further developed and brought into clinical trials by LimmaTech’s predecessor company, GlycoVaxyn, which she joined in 2007 as Group Leader in the Research Department. Her strong background in clinical research and regulatory affairs, along with a passion for improving global health through the development of safe and effective vaccines, drives her mission to address emerging antimicrobial resistance and global medical needs.